DTPa-HBV-IPV/Hib vaccine (Infanrix hexa). (Q35091918)

6 August 2017

title

DTPa-HBV-IPV/Hib vaccine (Infanrix hexa). (English)

1 reference

6 August 2017

1

Monique P Curran

1 reference

6 August 2017

Karen L Goa

2

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

63

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

673-82; discussion 683-4

1 reference

DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose

6 August 2017

cites work

1 reference

12 December 2020

1 reference

12 December 2020

Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis

1 reference

12 December 2020

Cost benefit of combining antigens

1 reference

12 December 2020

Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.

1 reference

12 December 2020

1 reference

12 December 2020

Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccin

1 reference

12 December 2020

Economic value to parents of reducing the pain and emotional distress of childhood vaccine injections

1 reference

12 December 2020

Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants.

1 reference

12 December 2020

Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule

1 reference

12 December 2020

Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines.

1 reference

12 December 2020

Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections

1 reference

12 December 2020

Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials

1 reference

12 December 2020

Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States

1 reference

12 December 2020

Immunogenicity of a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheria-tetanus-acellular pertussis-hepatitis B combination vaccine.

1 reference

12 December 2020

Combination vaccines: problems and promise

1 reference

12 December 2020

European Commission COST/STD Initiative. Report of the expert panel VIII. New vaccines, especially new combined vaccines

1 reference

12 December 2020

Developing better paediatric vaccines: the case of pertussis vaccine

1 reference

12 December 2020

Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination

1 reference

12 December 2020

Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine

1 reference

12 December 2020

1 reference

12 December 2020

Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates

1 reference

12 December 2020

Clinical relevance of lower Hib response in DTPa-based combination vaccines

1 reference

12 December 2020

Development and clinical application of new polyvalent combined paediatric vaccines

1 reference

12 December 2020

Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine in infancy.

1 reference

12 December 2020

A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection

1 reference

12 December 2020

Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine.

1 reference

12 December 2020

Diphtheria-pertussis-tetanus vaccine: reactogenicity of commercial products

1 reference

12 December 2020

10.2165/00003495-200363070-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

6 August 2017

1039979498

0 references

1 reference